Article
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
26 Mar 2021
Abstract excerpt
Autoimmune disease development depends on multiple factors, including genetic and environmental. Abnormalities such as sialylation levels and/or quality have been recently highlighted. The adjunction of sialic acid at the terminal end of glycoproteins and glycolipids is essential for distinguishing between self and non-self-antigens and the control of pro- or anti-inflammatory immune reactions. In autoimmunity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
